期刊
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
卷 137, 期 -, 页码 804-809出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.saa.2014.08.081
关键词
Moxifloxacin; Inclusion complex; beta-CD; FTIR; NMR; Fluorescence spectroscopy
类别
The supramolecular interaction of Moxifloxacin (Moxi) and beta-cyclodextrin (beta-CD) has been examined by FTIR, (HNMR)-N-1, SEM and fluorescence spectroscopy. The formation of inclusion complex has been confirmed on the base of changes of spectroscopy properties. The results showed that beta-CD reacted with Moxi to form an inclusion complex. The Moxi and beta-CD complex formed a host-guest complex in 1:1 stoichiometry and inclusion constant (K = 3.95 x 10(2)L mol(-1)) was ascertained by the typical double reciprocal plots. Furthermore, the thermodynamic parameters (Delta H degrees, Delta S degrees and Delta G degrees ) associated with the inclusion process were also determined. Based on the significant enhancement of the fluorescence intensity of Maxi produced through complex formation, a simple, accurate, rapid and highly sensitive spectrofluorometric method for the determination of Moxi in pharmaceutical formulation was developed. The measurement of relative fluorescence intensity was carried out at 464 nm with excitation at 289 nm. The factors affecting the inclusion complex formation were studied and optimized. Under the optimum reaction conditions, linear relationships with good correlation coefficients (0.99973) were in the concentration range of 10-60 ng/mL for spectrofluorimetry. The limit of detection (LOD) was found to be 1.6 ng/ mL. The proposed method was successfully applied to the analysis of Moxi in pharmaceutical preparation. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据